Medical machine maker CooperCompanies (NYSE: COO) has reported a rise in adjusted earnings for the second quarter of 2025, aided by a 6% income progress.
- CooperComapanies second-quarter income elevated 6% year-over-year to $1.0 billion, up 7% in fixed foreign money
- CooperVision income rose 5% to $669.6 million in Q2; CooperSurgical income moved up 8% to $332.7 million
- Second-quarter web revenue, on a per-share foundation, was $0.44, unchanged from final 12 months’s second quarter
- On an adjusted foundation, earnings climbed 12% year-over-year to $0.96 per share in the course of the three months
- Q2 gross margin was 68%, in comparison with 67% in final 12 months’s second quarter; adjusted gross margin was 68%
- Working margin moved up to18% in Q2 from 17% within the prior-year quarter, pushed by stronger gross margins and focused expense leverage
- Throughout the quarter, the corporate repurchased round 537.2 thousand shares for about $40.6 million
- For fiscal 2025, the administration expects whole income to be between $4.17 billion and $4.146 billion; it sees natural income progress of 5-6%
